Apparatus and methods for treating excess intraocular fluid

US12589030B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12589030-B2
Application numberUS-202318359838-A
CountryUS
Kind codeB2
Filing dateJul 26, 2023
Priority dateJan 14, 2011
Publication dateMar 31, 2026
Grant dateMar 31, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An ocular drainage system is provided for treating diseases that produce elevated intraocular pressures, such as glaucoma, wherein the system includes an implantable device and an external control unit, the implantable device includes a non-invasively adjustable valve featuring at least one deformable tube and a disk rotatably mounted within a housing, such that rotation of the disk using the external control unit causes the disk to apply a selected amount of compression to the deformable tube, thereby adjusting the fluidic resistance of the deformable tube and regulating the intraocular pressure.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for treating excess fluid pressure within an eye, the method comprising: implanting an inlet catheter in the eye such that an inlet end of the inlet catheter is in fluid communication with an anterior chamber of the eye; implanting an outlet catheter in the eye, such that an outlet end of the outlet catheter is in fluid communication with a space beneath tissue of the eye; implanting an implantable device under a conjunctiva of the eye such that the implantable device is under a scleral flap or above a scleral surface of the eye, the implantable device comprising a fluidic channel extending between and in fluid communication with the inlet catheter and the outlet catheter; and draining aqueous humor from the anterior chamber of the eye through the inlet catheter, the fluidic channel of the implantable device, and the outlet catheter to the space beneath tissue of the eye responsive to a pressure differential across the inlet catheter and the outlet catheter to thereby maintain fluid pressure within the eye within a predetermined range, wherein a rate of drainage through the implantable device is based on a fluidic resistance of the fluidic channel of the implantable device. 2 . The method of claim 1 , wherein the inlet catheter comprises a rigid nozzle. 3 . The method of claim 2 , wherein implanting the inlet catheter in the eye comprises passing an inlet end of the rigid nozzle through a wall of the eye to communicate with aqueous humor in the anterior chamber of the eye. 4 . The method of claim 1 , wherein the outlet catheter comprises a flexible drainage tube. 5 . The method of claim 4 , wherein a distal region of the flexible drainage tube comprises one or more drainage holes. 6 . The method of claim 1 , wherein the outlet catheter comprises a Seton tube. 7 . The method of claim 1 , wherein the implantable device comprises a radius of curvature selected to accommodate a radius of curvature of the eye. 8 . The method of claim 1 , wherein implanting the implantable device under the conjunctiva of the eye comprises implanting the implantable device above the scleral surface of the eye. 9 . The method of claim 1 , wherein implanting the outlet catheter in the eye comprises implanting the outlet catheter in the eye, such that the outlet end of the outlet catheter is in fluid communication with an orbital fat space of the eye. 10 . The method of claim 1 , wherein implanting the outlet catheter in the eye comprises implanting the outlet catheter disposed on a stylet in the eye, the method further comprising removing the stylet from the outlet catheter after the outlet catheter is implanted and the outlet end of the outlet catheter is in fluid communication with the space beneath tissue of the eye. 11 . The method of claim 1 , wherein draining aqueous humor from the anterior chamber of the eye to the space beneath tissue of the eye comprises draining aqueous humor from the anterior chamber of the eye through the inlet catheter, the implantable device, and the outlet catheter to be absorbed by scleral tissue of the eye. 12 . The method of claim 1 , wherein draining aqueous humor from the anterior chamber of the eye to the space beneath tissue of the eye comprises draining aqueous humor from the anterior chamber of the eye through the inlet catheter, the implantable device, and the outlet catheter to a connecting vein network of the eye. 13 . The method of claim 1 , wherein the outlet catheter is fluidically coupled to a drainage plate, the method further comprising disposing the drainage plate on a surface of the eye such that aqueous humor may be absorbed into scleral tissue of the eye. 14 . The method of claim 13 , wherein the drainage plate comprises a curve configured to accommodate a curvature of the eye. 15 . The method of claim 1 , further comprising adjusting the fluidic resistance of the fluidic channel of the implantable device to thereby maintain fluid pressure within the eye within the predetermined range. 16 . The method of claim 15 , wherein, in an undeformed state, the fluidic channel of the implantable device comprises a flow area and a corresponding fluidic resistance, and wherein adjusting the fluidic resistance of the fluidic channel of the implantable device comprises deforming the fluidic channel to thereby adjust the flow area of the fluidic channel. 17 . The method of claim 16 , wherein deforming the fluidic channel reduces the flow area of the fluidic channel. 18 . The method of claim 1 , further comprising coupling an inlet end of the outlet catheter to an outlet port of the implantable device to thereby fluidically couple the outlet catheter with the implantable device. 19 . The method of claim 1 , further comprising applying a scleral patch over the implantable device.

Assignees

Inventors

Classifications

  • having plate-like flexible members · CPC title

  • Pumps having electric drive · CPC title

  • by using two or more rollers as squeezing elements, the rollers moving on an arc of a circle during squeezing · CPC title

  • Angular position of the shaft · CPC title

  • Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments (A61F9/008 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12589030B2 cover?
An ocular drainage system is provided for treating diseases that produce elevated intraocular pressures, such as glaucoma, wherein the system includes an implantable device and an external control unit, the implantable device includes a non-invasively adjustable valve featuring at least one deformable tube and a disk rotatably mounted within a housing, such that rotation of the disk using the e…
Who is the assignee on this patent?
Ecole Polytechnique Fed Lausanne Epfl, Ecole Polytechnique Fed Lausanne Epfl
What technology area does this patent fall under?
Primary CPC classification A61F9/00781. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).